未知生产厂商
Eprodisate slows the decline of renal function in AA amyloidosis.
Eprodisate slows the decline of renal function in AA amyloidosis.
Decline in renal function associated with Amyloid A (AA) amyloidosis can be slowed by eprodisate (Kiacta), a drug that inhibits the deposit of the complex protein in tissues. AA amyloidosis is a serious, frequently fatal disorder involving deposits of amyloid fibrils in various organs and tissues. It is a complication of many chronic inflammatory disorders, but little is known about its etiology or natural history. Eprodisate delays the progression of AA amyloidosis-associated renal disease.
Investigated for use/treatment in amyloidosis.
